Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets - PubMed (original) (raw)
Simvastatin induces activation of the serine-threonine protein kinase AKT and increases survival of isolated human pancreatic islets
Juan L Contreras et al. Transplantation. 2002.
Abstract
Background: Pancreatic islets are susceptible to myriad insults that occur during islet isolation and transplantation. Studies demonstrated the role of Akt in regulating pancreatic beta-cell growth and survival. Activation of Akt maintains Bad phosphorylation and prevents its binding to mitochondrial targets, decreases caspase-9 activity, and prevents the translocation of forkhead transcription factors (FKHR). Simvastatin activates Akt in mammalian cells; therefore, we investigated the role of simvastatin on human pancreatic islets (HPI) survival.
Methods: HPI were treated with simvastatin, with and without LY294002, an inhibitor of phosphoinositide 3-kinase. PI viability was examined with ethidium bromide-acridine orange, and apoptosis was examined using a quantitative assay. Akt, Bad, FKHR phosphorylation, and mitochondrial cytochrome release were analyzed by Western blots. Caspase-9 activity was assessed by a fluorometric assay. A limited number of HPI were transplanted after simvastatin treatment in diabetic NOD-SCID mice.
Results: Low levels of Akt phosphorylation (activation) were demonstrated early after islet isolation. Akt activation; increase in islet viability; and decrease in Bad phosphorylation, cytochrome release, caspase-9 activation, and translocation of FKHR were observed after simvastatin treatment, effects reversed by LY294002. Among recipients of islets without simvastatin, none demonstrated reversal of diabetes after the transplant. In contrast, 58% of the recipients given islets treated with simvastatin remained euglycemic 30 days after the transplant.
Conclusions: Targeting the survival pathway with simvastatin exerts a cytoprotective effect on isolated PI. Activation of the Akt pathway is a potential new therapeutic approach to reduce loss of functional islet mass to bolster success in clinical islet transplantation.
Similar articles
- FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, Coffer PJ. Dijkers PF, et al. J Cell Biol. 2002 Feb 4;156(3):531-42. doi: 10.1083/jcb.200108084. Epub 2002 Jan 28. J Cell Biol. 2002. PMID: 11815629 Free PMC article. - The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets.
Federici M, Hribal ML, Ranalli M, Marselli L, Porzio O, Lauro D, Borboni P, Lauro R, Marchetti P, Melino G, Sesti G. Federici M, et al. FASEB J. 2001 Jan;15(1):22-24. doi: 10.1096/fj.00-0414fje. Epub 2000 Nov 14. FASEB J. 2001. PMID: 11099486 - C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.
Soane L, Cho HJ, Niculescu F, Rus H, Shin ML. Soane L, et al. J Immunol. 2001 Aug 15;167(4):2305-11. doi: 10.4049/jimmunol.167.4.2305. J Immunol. 2001. PMID: 11490019 - Involvement of the Akt/PKB signaling pathway with disease processes.
Sen P, Mukherjee S, Ray D, Raha S. Sen P, et al. Mol Cell Biochem. 2003 Nov;253(1-2):241-6. doi: 10.1023/a:1026020101379. Mol Cell Biochem. 2003. PMID: 14619975 Review. - Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury.
Chong ZZ, Li F, Maiese K. Chong ZZ, et al. Histol Histopathol. 2005 Jan;20(1):299-315. doi: 10.14670/HH-20.299. Histol Histopathol. 2005. PMID: 15578447 Free PMC article. Review.
Cited by
- Gene transfer of active Akt1 by an infectivity-enhanced adenovirus impacts β-cell survival and proliferation differentially in vitro and in vivo.
Bone RN, Icyuz M, Zhang Y, Zhang Y, Cui W, Wang H, Peng JB, Matthews QL, Siegal GP, Wu H. Bone RN, et al. Islets. 2012 Nov-Dec;4(6):366-78. doi: 10.4161/isl.22721. Epub 2012 Nov 1. Islets. 2012. PMID: 23183538 Free PMC article. - Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial.
Martin S, Herder C, Schloot NC, Koenig W, Heise T, Heinemann L, Kolb H; DIATOR Study Group. Martin S, et al. PLoS One. 2011 Mar 11;6(3):e17554. doi: 10.1371/journal.pone.0017554. PLoS One. 2011. PMID: 21412424 Free PMC article. Clinical Trial. - Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial).
Strom A, Kolb H, Martin S, Herder C, Simon MC, Koenig W, Heise T, Heinemann L, Roden M, Schloot NC; DIATOR Study Group. Strom A, et al. PLoS One. 2012;7(3):e33108. doi: 10.1371/journal.pone.0033108. Epub 2012 Mar 20. PLoS One. 2012. PMID: 22448235 Free PMC article. Clinical Trial. - Inhibition of caspase-mediated PARP-1 cleavage results in increased necrosis in isolated islets of Langerhans.
Aikin R, Rosenberg L, Paraskevas S, Maysinger D. Aikin R, et al. J Mol Med (Berl). 2004 Jun;82(6):389-97. doi: 10.1007/s00109-004-0540-5. Epub 2004 Apr 23. J Mol Med (Berl). 2004. PMID: 15105993 - Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.
Barlow AD, Nicholson ML, Herbert TP. Barlow AD, et al. Diabetes. 2013 Aug;62(8):2674-82. doi: 10.2337/db13-0106. Diabetes. 2013. PMID: 23881200 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous